Hepatic Arterial Infusion Chemotherapy with Serplulimab and the Bevacizumab Biosimilar HLX04 for Advanced Hepatocellular Carcinoma: A Prospective, Observational Phase II Clinical Trial.
Saved in:
| Title: | Hepatic Arterial Infusion Chemotherapy with Serplulimab and the Bevacizumab Biosimilar HLX04 for Advanced Hepatocellular Carcinoma: A Prospective, Observational Phase II Clinical Trial. |
|---|---|
| Authors: | Li, Huikai1 (AUTHOR), Si, Tongguo2 (AUTHOR), Li, Rentao3 (AUTHOR), Xie, Xiaojing1,3 (AUTHOR), Liu, Yang1,2 (AUTHOR), Fu, Linlin3 (AUTHOR), Bai, Yu3 (AUTHOR), Yao, Junchao3 (AUTHOR), Zhang, Xihao3 (AUTHOR), Yang, Mao2 (AUTHOR), Mu, Xiaofeng3 (AUTHOR) fenglei557@163.com |
| Source: | Cancers. Oct2025, Vol. 17 Issue 19, p3235. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
